HEALTH● LOWAug 6 · Aug 6, 2026, 5:35 PM
Lexicon anticipates Zynquista NDA resubmission in Q4 2026 as SONATA-HCM top line data expected in Q1 2027
Seeking Alpha Tech
Lexicon expects to resubmit the New Drug Application (NDA) for Zynquista in the fourth quarter of 2026. Additionally, top-line data from the SONATA-HCM trial is anticipated in the first quarter of 2027.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH45m agoPT Health Watch: What to do as extreme heat hits NigeriaPremium TimesHEALTH2h agoManila Doctors Hospital , Benilde partner for accessible servicesphilstar.com · PhilippinesHEALTH2h agoHealth insurance costs keep climbing for American workers , a new survey findsabc13.com · United StatesHEALTH2h agoNMC withdraws 2023 rules on medical education standards, raising accountability concernsThe Hindu